ublic health measures to limit the spread of coronavirus disease 2019 (COVID-19) include requirements not to leave home except for specified purposes, to work from home when practical, to limit proximity to other people, to not visit residential aged care homes, to limit the number of people at social events (weddings, funerals, celebrations), to restrict interstate and international travel, and to accept the enforcement of these restrictions. The mental health consequences of these measures are likely to be unevenly distributed across the community because they also depend on individual social and economic circumstances. A recent position paper 1 summarised international expert opinion on research priorities for mental health during the COVID-19 pandemic. The first recommendation was to gather high quality population level data on its mental health effects. The aim of our study was to assess the mental health of people in Australia during the first month of COVID-19-related restrictions. Our specific objectives were to estimate population prevalence rates of clinically significant symptoms of depression, generalised anxiety, thoughts of being better off dead, increased irritability, and high optimism about the future; to estimate the prevalence of direct experiences of COVID-19, loss of employment caused by COVID-19 restrictions, concern about contracting COVID-19, and major disadvantage because of the restrictions; and to assess associations between these experiences and mental health symptoms. Methods A short, anonymous survey (estimated completion time, 8 minutes) of people living in Australia and aged at least 18 years was available on the Monash University website (https:// www.monash.edu/medic ine/living-with-covid-19-restr ictio nssurvey) from 3 April 2020 (four days after national stage two COVID-19 restrictions were announced by the Prime Minister; phase one restrictions had been gradually introduced during March) until midnight on 2/3 May 2020 (further information: online Supporting Information). Mental health Psychological symptoms experienced during the preceding fortnight were assessed with the Patient Health Questionnaire 9 (PHQ-9) and the Generalised Anxiety Disorder Scale (GAD-7). The PHQ-9 2 is an easily understood scale that asks respondents to rate their experience of nine symptoms from 0 (not experienced) to 3 (experienced nearly every day); a total PHQ-9 score of 10 or more indicates clinically significant (moderate to severe) symptoms, while scores of 5-9 indicate mild symptoms. The GAD-7 3 is an easily understood scale that asks respondents to rate their experience of seven symptoms of anxiety with the same response options as the PHQ-9; a total GAD-7 score of 10 or more indicate clinically significant (moderate to severe) symptoms, while scores of 5-9 indicate mild symptoms. Optimism about the future was assessed with a visual analogue scale (from 0, not at all optimistic, to 10, extremely optimistic).

Among Indian HIV-infected women, we found a high incidence of postpartum TB and associated postpartum maternal and infant death. Active screening and targeted use of isoniazid preventative therapy among HIV-infected women in India should be considered to prevent postpartum maternal TB and associated mother-to-child morbidity and mortality.

No abstract

Background: The risk for occupational exposure to HIV has been well characterized in the developed world, but limited information is available about this transmission risk in resource-constrained settings facing the largest burden of HIV infection. In addition, the feasibility and utilization of post-exposure prophylaxis (PEP) programs in these settings are unclear. Therefore, we examined the rate and characteristics of occupational exposure to HIV and the utilization of PEP among health care workers (HCW) in a large, urban government teaching hospital in Pune, India.

No abstract